Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)
- Citation:
- Cancer vol 120 (22) 3575-3583
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- 971 is parent abstract
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA035267, CA33601, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, U10 CA031946, U10 CA033601, CA-35195, U10 CA037404, N01 CA035119, U10 CA063848, U10 CA035195, CA-35103, CA-25224, U10 CA035272, CA-35113, U10 CA035101, UG1 CA189823, U10 CA035113, P30 CA015083, CA-63848, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, U10 CA035119, CA-37417, CA-35272, CA-35269, CA-35101, U10 CA025224, CA31946, CA-35267, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Debra L. Barton Gita Thanarajasingam Jeff A. Sloan Brent Diekmann Jyotsna Fuloria Lisa A. Kottschade Alan P. Lyss Anthony J. Jaslowski Miroslaw A. Mazurczak Scott C. Blair Shelby Terstriep Charles L. Loprinzi
- Networks:
- Study
- NCCTG-N08C3
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- gabapentin, delayed nausea, delayed vomiting, antiemetic therapy, randomized controlled trial